Skip to main content
Premium Trial:

Request an Annual Quote

BioChem Strikes Deal To Use Bioinformatics Technologies from SBI

Premium

SAN DIEGO--Structural Bioinformatics (SBI) here and BioChem Therapeutics, a wholly owned subsidiary of Biochem Pharma, Laval, Quebec, have agreed to collaborate on drug discovery and design using SBI's proprietary computational technologies. SBI will apply its genomics-driven, protein-structure-based drug design algorithms to facilitate the design and identification of small molecules for two targets selected by BioChem. BioChem will contribute drug development expertise, fund the research, and make milestone and royalty payments.

"We are very excited about the drug development synergy that this collaboration will create," said Edward Maggio, SBI's president and CEO. "BioChem Therapeutics' drug optimization expertise is a perfect extension of Structural Bioinformatics' computer-assisted drug design capabilities."

SBI has developed a structure-based lead discovery pathway to generate small-molecule lead compounds. The pathway relies on the company's large protein structural information database that is tightly integrated with a proprietary set of computational tools. The resulting operating system permits the identification and structural analysis of relevant sites on protein drug targets, and the direct use of this information in a variety of structure-based drug design and virtual screening applications, according to the company.

SBI, which is privately held, recently closed a new $5 million funding round.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.